Fertility medication study for IVF with frozen embryo transfer
Treatments studied
Part of Hormones & metabolism, Women’s health & pregnancy clinical trials.
This study tests a fertility medication (human menopausal gonadotropin) to see how well it helps women have a live birth after IVF with frozen embryos. It compares the medication's effectiveness for women with infertility who are planning to freeze all embryos and transfer them later.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman aged 18 to 42, with a BMI between 18 and 38 (you can ask your doctor what your BMI is if you're unsure).
- You have regular menstrual cycles (21 to 35 days) and a blood test showing your egg reserve (AMH) is above 1.2 ng/ml within the last 6 months.
- You have a normal uterine check (for example, by ultrasound or a test that looks at the inside of your uterus) within the past year.
- You are willing to undergo up to two cycles of egg stimulation and retrieval, freeze the embryos, and then have a frozen embryo transfer (FET) with one tested (euploid) embryo.
- You are not using donor sperm for the main fertilization, and you are not planning to use a gestational carrier (another woman to carry the pregnancy).
- You agree to have a small sample of cells taken from the embryo (trophectoderm biopsy) to check the chromosomes before freezing.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a fertility drug called follitropin delta for women undergoing IVF. It checks if using this drug with a specific hormone-lowering protocol helps produce eggs for fertilisation.
This study tests different medication approaches to help women who had a low number of eggs in a previous IVF cycle produce more eggs this time. The goal is to find a better stimulation method for women with this 'low response' pattern.
This trial is studying whether a specific fertility medication (hMG) helps improve embryo quality during IVF when you are also doing genetic testing of embryos. It may help you have better embryos for transfer.
This trial compares two doses of follicle-stimulating hormone (FSH) to find out which dose helps women with normal ovarian reserve have better IVF outcomes. It aims to improve the chances of a successful pregnancy.
This trial tests whether giving a medication called a GnRH agonist (which affects hormones) before a frozen embryo transfer can improve the chances of pregnancy in women with infertility. It aims to see if this treatment helps the uterus accept the embryo better.
This study compares two fertility medications (rFSH and hMG) to see how they affect the cells around your eggs and the quality of embryos. It may help you and your doctor choose the best stimulation drug for your IVF cycle.
Hear when a new Infertility (IVF Patients) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.